AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND POSTMENOPAUSE.

Education

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Public Health Committee
Last action: 2026-04-15
Official status: Tabled for the Calendar, House
Effective date: Not listed

Plain English Breakdown

Checked against official source text during the last sync.

Act to Create a Toolkit for Treating Menopause Symptoms

This law requires the state Department of Public Health to create and share a guide that helps doctors diagnose and treat menopause, perimenopause, and postmenopause.

What This Bill Does

Requires the Department of Public Health to develop a toolkit with practical guidance for health care providers.
Mandates collaboration with experts from The University of Connecticut Health Center's Health Disparities Institute.
Includes input from people who have experienced menopause symptoms and doctors who treat them.
Sets specific deadlines to distribute the first version by June 1, 2028, and a revised version by January 1, 2029.
Requires the toolkit to cover symptom descriptions, treatment options like hormone therapy, insurance coverage details, and continuing education modules.

Who It Names or Affects

The Department of Public Health
Health care providers in fields such as obstetrics, gynecology, internal medicine, family medicine, emergency medicine, psychiatry, mental health, social work, dentistry, dental hygiene, and community health.
People who have experienced symptoms of perimenopause, menopause, or postmenopause.

Limits and Unknowns

The law does not specify how much money will be used to create or distribute the toolkit.
The final content of the education modules depends on what qualifies as continuing education for health care providers.
The act takes effect on October 1, 2026.

Bill History

2026-04-15 Connecticut General Assembly
No New File by Committee on Appropriations
2026-04-15 Connecticut General Assembly
Tabled for the Calendar, House
2026-04-14 LCO
Filed with Legislative Commissioners' Office
2026-04-14 LCO
Reported Out of Legislative Commissioners' Office
2026-04-13 APP
Joint Favorable
2026-04-07 Connecticut General Assembly
Referred by House to Committee on Appropriations
2026-03-23 LCO
Reported Out of Legislative Commissioners' Office
2026-03-23 Connecticut General Assembly
Favorable Report, Tabled for the Calendar, House
2026-03-23 Connecticut General Assembly
House Calendar Number 108
2026-03-23 LCO
File Number 114
2026-03-16 LCO
Referred to Office of Legislative Research and Office of Fiscal Analysis 03/23/26 12:00 PM
2026-03-10 LCO
Filed with Legislative Commissioners' Office
2026-03-09 PH
Joint Favorable Substitute
2026-02-27 Connecticut General Assembly
Public Hearing 03/04
2026-02-26 Connecticut General Assembly
Referred to Joint Committee on Public Health

Official Summary Text

To require the development and distribution of a provider toolkit for the diagnosis and treatment of menopause, perimenopause and postmenopause.

Current Bill Text

Read the full stored bill text

LCO 1 of 2

General Assembly Substitute Bill No. 5389
February Session, 2026

AN ACT CONCERNING A PROVIDER TOOLKIT FOR THE DIAGNOSIS
AND TREATMENT OF MENOPAUSE, PERIMENOPAUSE AND
POSTMENOPAUSE.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:

Section 1. (NEW) (Effective October 1, 2026 ) (a) The Department of 1
Public Health, in consultation with The University of Connecticut 2
Health Center's Health Disparities Institute, persons who have 3
experienced symptoms of perimenopause, menopause and 4
postmenopause, and health care providers who treat persons with 5
symptoms of perimenopause, menopause and postmenopause, shall 6
develop a toolkit that provides practical, evidence-based and culturally 7
appropriate guidance to health care providers in the state who are 8
responsible for diagnosing or treating persons with symptoms of 9
menopause, perimenopause or postmenopause, as determined by the 10
commissioner, including, but not limited to, health care providers in the 11
fields of obstetrics, gynecology, internal medicine, family medicine, 12
emergency medicine, psychiatry, mental health, social work, dentistry, 13
dental hygiene and community health, regarding best practices for 14
screening, identification, clinical assessment, diagnosis and treatment of 15
symptoms of menopause, perimenopause and postmenopause. Such 16
guidance shall include, but need not be limited to, (1) a comprehensive 17
description of the symptoms of menopause, perimenopause and 18
Substitute Bill No. 5389

LCO 2 of 2

postmenopause, (2) evidence -based guidelines regarding the 19
identification and treatment of such symptoms, including, but not 20
limited to, the use of hormones, such as hormone replacement therapy 21
and testosterone therapy, (3) the availability of insurance coverage for 22
such therapies, and (4) short education modules regarding such 23
guidance that would qualify as continuing education for such health 24
care providers. 25
(b) Not later than June 1, 2028, the Commissioner of Public Health 26
shall distribute the toolkit developed pursuant to subsection (a) of this 27
section to such health care providers. Not later than January 1, 2029, the 28
commissioner shall (1) evaluate any feedback received from such health 29
care providers regarding the effectiveness of the toolkit, (2) revise the 30
toolkit as necessary to address such feedback, and (3) distribute a 31
revised toolkit, if any, to such health care providers. 32
This act shall take effect as follows and shall amend the following
sections:

Section 1 October 1, 2026 New section

PH Joint Favorable Subst.
APP Joint Favorable